Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects

• Published in: The journal of clinical endocrinology and metabolism Vol. 64; no. 5; p. 975
• Main Authors: Vora, J, Owens, D R, Luzio, S, Atiea, J, Ryder, R, Hayes, T M
• Format: Journal Article
• Language: English
• Published: United States 01-05-1987
• Subjects: Adult; Chromium Radioisotopes; Diabetes Mellitus, Type 1 - physiopathology; Edetic Acid; Glomerular Filtration Rate - drug effects; Humans; Iodine Radioisotopes; Iodohippuric Acid; Kidney - drug effects; Kidney - physiopathology; Male; Renal Circulation - drug effects; Somatostatin - pharmacology; Urine
• ISSN: 0021-972X
• DOI: 10.1210/jcem-64-5-975

The acute effects of iv somatostatin (SRIH; 100 micrograms/h) on the urinary flow (Uvol), effective renal plasma flow (RPF), and glomerular filtration rate (GFR) were compared with those of a control infusion of 0.15 M NaCl in nine insulin-dependent diabetic (IDD) patients of less than 10 yr disease duration and six normal subjects (NS). RPF and GFR were measured using a standard primed constant isotope infusion of [125I]iodohippurate and [51Cr]chromium EDTA. Uvol, RPF, and GFR were measured during 20-min clearance periods. During the NaCl infusion mean Uvol, RPF, and GFR were 14.1 +/- 0.2 (+/- SEM), 708 +/- 4, and 150 +/- 1 mL/min in the IDD group and 12.7 +/- 0.4, 568 +/- 5, and 110 +/- 2 mL/min in the NS group, respectively. In the IDD patients Uvol, RPF, and GFR decreased from 16.6 +/- 1.8, 670 +/- 30, 146 +/- 4 mL/min pre-SRIH to 9.2 +/- 1 (P less than 0.001), 553 +/- 25 (P less than 0.001), and 130 +/- 5 (P less than 0.001) mL/min, respectively, at 120 min during the SRIH infusion. Similarly, in the NS group mean Uvol, RPF, and GFR were 14.2 +/- 0.6, 552 +/- 15, and 112 +/- 5 mL/min pre-SRIH and decreased to 7.4 +/- 0.6 (P less than 0.001), 422 +/- 7 (P less than 0.001), and 93 +/- 3 (P less than 0.001) mL/min, respectively, after 120 min of the SRIH infusion. SRIH, therefore, had a profound effect on renal function in both IDD patients and NS, resulting in a reduction in RPF, GFR, and, as a consequence, Uvol.